Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy of Dexamethasone Treatment for Patients With ARDS Caused by COVID-19

NCT04325061 is registered in ClinicalTrials.gov with Hospital Universitario de Gran Canaria Doctor Negrín as lead sponsor.

NCT NCT04325061
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04325061 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy of Dexamethasone Treatment for Patients With ARDS Caused by COVID-19
Lead sponsor
Hospital Universitario de Gran Canaria Doctor Negrín
Phase
Phase 4
Overall status
Terminated
Start date
April 3, 2020
Completion date
June 19, 2020
Enrollment
19 (actual)
Sites
24

Conditions

As the registry lists them; a condition with its own page is linked.

acute respiratory distress syndrome caused by covid-19